Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Apollo Endosurgery Inc (NQ: APEN )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Apr 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Apollo Endosurgery Inc

< Previous 1 2 Next >
Apollo Endosurgery Announces Two Important Milestones in the Advancement of Endoscopic Procedures for Patients Living with Obesity
Via ACCESSWIRE
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Apollo Endosurgery, Inc. (Nasdaq - APEN), Imago BioSciences, Inc. (Nasdaq - IMGO), Opiant Pharmaceuticals Inc. (Nasdaq - OPNT), Benefitfocus, Inc. (Nasdaq - BNFT)
From Brodsky & Smith LLC
Via GlobeNewswire
APOLLO ENDOSURGERY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apollo Endosurgery, Inc. - APEN
From Kahn Swick & Foti, LLC
Via Business Wire
Apollo Endosurgery to be Acquired by Boston Scientific
Via ACCESSWIRE
Apollo Endosurgery, Inc. Reports Record $19.6 million Global Revenue in Third Quarter 2022
Via ACCESSWIRE
Endoscopic Sleeve Gastroplasty (ESG) Procedure Featured as a "Top 10" Paper at the IFSO 2022 World Congress in Miami
Via ACCESSWIRE
Apollo Endosurgery (NASDAQ: APEN) Enters Into Agreement to be Acquired by Boston Scientific (NYSE: BSX) for $615 Million
Apollo Endosurgery, Inc. (NASDAQ: APEN) is a medical technology company, which is focused on the research and development of advanced, 
Via Spotlight Growth
Exposures Product Safety
APEN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Apollo Endosurgery, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Apollo Endosurgery Completes Transition to European MDR Requirements for the OverStitch Systems, BIB and Orbera 365 intragastric balloons, and OverTube.
Via ACCESSWIRE
Apollo Endosurgery to Participate in Upcoming Investor Conferences
Via ACCESSWIRE
Apollo Endosurgery, Inc. Reports Record Global Revenue in Second Quarter 2022
Via ACCESSWIRE
Apollo Endosurgery Announces Publication in the Lancet of Landmark Study for the Endoscopic Sleeve Gastroplasty Procedure
Via ACCESSWIRE
Apollo Endosurgery to Report Third Quarter Results on November 1, 2022
Via ACCESSWIRE
Apollo Endosurgery Announces Publication in the Lancet of Landmark Study for the Endoscopic Sleeve Gastroplasty Procedure
Publication of MERIT Study Follows FDA Market Authorization of Apollo ESG™ 
From Apollo Endosurgery, Inc.
Via AccessWire
Exposures Product Safety
Apollo Endosurgery to Report Second Quarter Results on August 2, 2022
Via ACCESSWIRE
Apollo Endosurgery to Report Second Quarter Results on August 2, 2022
AUSTIN, TX / ACCESSWIRE / July 21, 2022 / Apollo Endosurgery, Inc. ("Company" or "Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and... 
From Apollo Endosurgery, Inc.
Via AccessWire
FDA Grants De Novo Marketing Authorization to Apollo Endosurgery for Apollo ESG(TM) and Apollo REVISE(TM), New Endoscopic Systems for Patients with Obesity
Systems Offer Effective, Minimally Invasive Treatment Options for Millions of Patients with Obesity (BMI 30-50 kg/m2) 
From Apollo Endosurgery, Inc.
Via AccessWire
Exposures Product Safety
FDA Grants De Novo Marketing Authorization to Apollo Endosurgery for Apollo ESG and Apollo REVISE, New Endoscopic Systems for Patients with Obesity
Via ACN Newswire
Exposures Product Safety
Sharon O'Keefe Joins Apollo Endosurgery Board of Directors
Seasoned healthcare leader brings 30 years of hospital system and medical technology expertise 
From Apollo Endosurgery, Inc.
Via AccessWire
Digestive Disease Week 2022 Adds to the Growing Wave of Clinical Evidence Supporting Significant Opportunity for Apollo Endosurgery Products
AUSTIN, TX / ACCESSWIRE / May 31, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures,... 
From Apollo Endosurgery, Inc.
Via AccessWire
Apollo Endosurgery Products to Take Center Stage at Digestive Disease Week
AUSTIN, TX / ACCESSWIRE / May 18, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures,... 
From Apollo Endosurgery, Inc.
Via AccessWire
Apollo Endosurgery, Inc. Reports 33% U.S. Revenue Growth in First Quarter 2022
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence. 
From Apollo Endosurgery, Inc.
Via AccessWire
Apollo Endosurgery to Report First Quarter Results on May 3, 2022
AUSTIN, TX / ACCESSWIRE / April 13, 2022 / Apollo Endosurgery, Inc. ("Company" or "Apollo") (Nasdaq:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and... 
From Apollo Endosurgery, Inc.
Via AccessWire
Apollo Endosurgery Appoints Jeannette Bankes to Board of Directors
Veteran Brings 30 Years of Multinational Healthcare Leadership Experience AUSTIN, TX / ACCESSWIRE / April 4, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally... 
From Apollo Endosurgery, Inc.
Via AccessWire
Apollo Endosurgery to Participate in the Cowen Healthcare Conference
AUSTIN, TX / ACCESSWIRE / March 2, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, today... 
From Apollo Endosurgery, Inc.
Via AccessWire
Apollo Endosurgery, Inc. Reports 50% Revenue Growth in 2021
- Increased adoption across all product lines in both U.S. and international - Grew fourth quarter 2021 revenue 26% AUSTIN, TX / ACCESSWIRE / February 22, 2022 / Apollo Endosurgery, Inc. ("Apollo")... 
From Apollo Endosurgery, Inc.
Via AccessWire
Apollo Endosurgery to Report Fourth Quarter and Full Year Results on February 22, 2022
AUSTIN, TX / ACCESSWIRE / February 10, 2022 / Apollo Endosurgery, Inc. ("Company" or "Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal... 
From Apollo Endosurgery, Inc.
Via AccessWire
Apollo Endosurgery Appoints Keely Scamperle as Vice President of Reimbursement and Market Access
Veteran Leader Brings 25 Years of Global Medical Device Experience AUSTIN, TX / ACCESSWIRE / January 18, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive... 
From Apollo Endosurgery, Inc.
Via AccessWire
Apollo Endosurgery Announces Preliminary 2021 Revenue Results; Reflecting 50% Growth Over 2020
Fourth quarter 2021 revenue grew 25% over 2020 AUSTIN, TX / ACCESSWIRE / January 10, 2022 / Apollo Endosurgery, Inc. ("Apollo" or the "Company") (NASDAQ:APEN), a global leader in less invasive medical... 
From Apollo Endosurgery, Inc.
Via AccessWire
Apollo Endosurgery Announces New $100 Million Senior Secured Term Loan Facility from Innovatus Capital Partners, LLC
- $35 million funded at close to refinance existing debt, extend maturity and lower interest expense - Additional borrowing capacity provides minimally dilutive growth capital and strategic flexibility... 
From Apollo Endosurgery, Inc.
Via AccessWire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.